Featured News

CSL Behring has awarded four advocacy grants totaling $87,000 to patient organizations in the U.S. through its Local Empowerment for Advocacy Development (LEAD) program. LEAD grants support grassroots advocacy efforts by organizations committed to helping people who use plasma-derived or recombinant therapies to manage their health conditions.

A new human retrovirus, discovered in 2006 from tissue samples of a rare human prostate cancer, has some health officials concerned that it might be transmissible via blood transfusions.

Last month, Congresswoman Carolyn McCarthy (D-NY) introduced legislation to promote awareness of and screening for all bleeding disorders.  The bill is H.R. 4846, the Bleeding Disorder Screening, Awareness, and Further Education (SAFE) Act.

President Obama's Fiscal Year (FY) 2011 proposed budget, released on February 1, eliminated funding for the existing hemophilia program at the U.S. Centers for Disease Control and Prevention (CDC), reallocating them to a new program called a "public health approach to blood disorders."

Last month, President Obama signed sweeping healthcare reform legislation into law.  Read a summary of the health reform legislation. Some provisions of the law will become effective as early as the end of June and many others by September.

Novo Nordisk, Visionary Corporate Partner and Lead Benefactor of the Campaign for Our Future, has committed an additional $600,000 toward Phase II of the Campaign – Research is Our Future, which will focus on advancing NHF’s research program.

On February 26 and 27, 2010, 43 of NHF’s 46 chapters came together in Washington, D.C. for NHF’s Leadership Weekend Training. Executive Directors and community leaders discovered new tools and learned new skills to help them in their

HemAware, the National Hemophilia Foundation’s award-winning, magazine is now available online. When you go to www.hemaware.org, you will find an easy-to-navigate, interactive Web site planned with you in mind.